Form D · Biotechnology
Helixbind, Inc.
Marlborough, MA · CIK 0001599879
Offering snapshot reported Oct 24, 2017 · SEC filing
- Reported sold
- $2.86M Offering amount: $2.86M
- Investors reported
- 29 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 25, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 24, 2017 | Initial | $2,864,371 | No comparison | 29 | SEC filing |
| Feb 24, 2014 | Initial | $1,650,000 | No comparison | 14 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-297313
Source: Form D, filed Oct 24, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Sheppard Mollick | Director |
| Larry Pearson | Director |
| Alon Singer | Director, Executive, Promoter |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
181 Cedar Hill Street
Marlborough, MA, 01752
Marlborough, MA, 01752